05.11.19 | Vollzeit | Zug | headcount AGTreatment therapies. Their industry-leading antibody-drug conjugate (ADC) technology harnesses antibodies' specificity to administer direct and targeted oncotoxin treatments. In addition to their main marketed product, they are advancing a promising product pipeline of other novel oncotherapies for both
Später ansehen31.10.19 | Vollzeit | Zug | headcount AGA minimum of 25% international travel, mostly within Europe FURTHER INFORMATION Our client is an emerging global multi-product biotech company developing and commercializing innovative antibody-based cancer treatment therapies. Their industry-leading antibody-drug conjugate (ADC) technology harnesses
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Pharmaceutical Production Lead in Zug kostenlos abonnieren.